Due to the prominent role of PI3K/Akt/mTOR and MEK/ERK signaling pathways in the phosphorylation of FOXO3a, inhibiting these two signaling pathways can be an promising method for differentiation therapy against high-grade gliomas, especially GBM [137, 196, 221]. This evidence concerns the gene AKT1 and central nervous system cancer.